Kallman Thomas F, Bäckryd Emmanuel, Söderlund Schaller Anne
Pain and Rehabilitation Center, and Department of Health, Medicine and Caring Sciences, Linköping University, Brigadgatan 22, Linköping, SE-581 85, Sweden.
Sci Rep. 2025 Aug 13;15(1):29672. doi: 10.1038/s41598-025-15113-6.
Opioid prescribing for patients with chronic non-cancer pain is common despite issues associated with long-term efficacy, functional improvement, and safety. Pain specialists assess many patients with chronic non-cancer pain, but their experiences of this situation are not well represented in prior qualitative research. The aim of this study was to explore pain specialists' experiences of prescribing opioids to patients with chronic non-cancer pain. We adhered to the Consolidated Criteria for Reporting Qualitative Research guidelines. Pain specialists in Sweden were recruited by purposive and snowball sampling. Participants were digitally interviewed, audio and video were recorded, and interviews translated verbatim. Data was analyzed through manifest inductive content analysis. Twenty pain specialists were interviewed. Qualitative content analysis revealed that the pain specialists' experiences were represented by two main categories: (1) Navigating the doctor-patient relationship, and (2) Challenges and opportunities when prescribing opioids. The first main category describes the relational demands associated with opioid prescribing and includes communication, conflicts, managing expectations, and the emotional and ethical aspects of prescribing opioids. The second main category describes handling complexity and heterogeneity, organizational aspects, and the doctor's due diligence when prescribing opioids. Our results offer new insights into pain specialists' experiences of prescribing opioids for chronic non-cancer pain, offering health care professionals guidance for responsible opioid prescribing. Pain specialists highlight the need for structured pain assessments and identify system-level improvements, such as allocating sufficient time, enabling team-based care, and continued education initiatives, to support safe opioid use in health care.
尽管存在与长期疗效、功能改善和安全性相关的问题,但为慢性非癌性疼痛患者开具阿片类药物的情况仍很常见。疼痛专家会评估许多慢性非癌性疼痛患者,但他们在这种情况下的经历在以往的定性研究中并未得到充分体现。本研究的目的是探讨疼痛专家为慢性非癌性疼痛患者开具阿片类药物的经历。我们遵循了《定性研究报告的统一标准》指南。通过目的抽样和滚雪球抽样的方式招募了瑞典的疼痛专家。对参与者进行了数字访谈,记录了音频和视频,并逐字翻译了访谈内容。通过显性归纳内容分析法对数据进行了分析。共访谈了20名疼痛专家。定性内容分析表明,疼痛专家的经历主要体现在两个主要类别中:(1)处理医患关系,以及(2)开具阿片类药物时的挑战与机遇。第一个主要类别描述了与开具阿片类药物相关的关系需求,包括沟通、冲突、管理期望以及开具阿片类药物的情感和伦理方面。第二个主要类别描述了在开具阿片类药物时处理复杂性和异质性、组织方面以及医生的尽职调查。我们的研究结果为疼痛专家为慢性非癌性疼痛开具阿片类药物的经历提供了新的见解,为医疗保健专业人员进行负责任的阿片类药物处方提供了指导。疼痛专家强调了进行结构化疼痛评估的必要性,并确定了系统层面的改进措施,例如分配足够的时间、实现团队协作护理以及开展继续教育活动,以支持在医疗保健中安全使用阿片类药物。
Clin Orthop Relat Res. 2025-1-1
Health Soc Care Deliv Res. 2024-9-25
JBI Database System Rev Implement Rep. 2016-4
JAMA Netw Open. 2025-5-1
Clin Orthop Relat Res. 2024-2-1
Scand J Pain. 2024-12-23
J Pain Palliat Care Pharmacother. 2024-12